Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response

CardioVascular and Interventional Radiology

Volumn 36, Issue 4, 2013, Pages 1030-1038

  Wang, Xiaodong ^a,b   Erinjeri, Joseph P ^a   Jia, Xiaoyu ^a   Gonen, Mithat ^a   Brown, Karen T ^a   Sofocleous, Constantinos T ^a   Getrajdman, George I ^a   Brody, Lynn A ^a   Thornton, Raymond H ^a   Maybody, Majid ^a   Covey, Ann M ^a   Siegelbaum, Robert H ^a   Alago, William ^a   Solomon, Stephen B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Clinical practice; Embolization; Embolotherapy; Hepatic; Liver

Indexed keywords

POLYVINYL ALCOHOL;

ABLATION THERAPY; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; COMPLETE RESPONSE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST; CONTROLLED STUDY; DEFECTS CONTRAST RETENTION; ENDOCRINE LIVER METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MODIFIED RESPONSE EVALUATION CRITERIA IN SOLID TUMORS; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARTICLE EMBOLIZATION; PREDICTION; PRIORITY JOURNAL; RETAINED CONTRAST; THYROID MEDULLARY CARCINOMA; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR CONTRAST RETENTION; TUMOR VOLUME; VASCULAR CONTRAST RETENTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COHORT STUDIES; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PARTICLE SIZE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOGRAPHIC IMAGE ENHANCEMENT; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879990947     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0506-x     Document Type: Article

References (25)

1. Dhanasekaran R, Kooby DA, Staley CA et al (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol 101(6):476-480
2. Kim JH, Yoon HK, Ko GY et al (2010) Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 255(1):270-277
3. Nazario J, Gupta S (2010) Transarterial liver-directed therapies of neuroendocrine hepatic metastases. Semin Oncol 37(2):118-126
4. Malagari K, Pomoni M, Spyridopoulos TN et al (2011) Safety profile of sequential transcatheter chemoembolization with DC Bead: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovasc Intervent Radiol 34(4):774-785
5. Liapi E, Geschwind JF (2010) Chemoembolization for primary and metastatic liver cancer. Cancer J 16(2):156-162
6. Lencioni R, de Baere T, Burrel M et al (2011) Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol 35:980-985
7. Tadavarthy SM, Knight L, Ovitt TW et al (1974) Therapeutic transcatheter arterial embolization. Radiology 112(1):13-16
8. Allison DJ, Modlin IM, Jenkins WJ (1977) Treatment of carcinoid liver metastases by hepatic-artery embolisation. Lancet 2(8052-8053):1323-1325
9. Bonomo G, Pedicini V, Monfardini L et al (2010) Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up. Cardiovasc Intervent Radiol 33(3):552-559
10. Covey AM, Maluccio MA, Schubert J et al (2006) Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer 106(10):2181-2189
11. Maluccio MA, Covey AM, Porat LB et al (2008) Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 19(6):862-869
12. Lewis AL, Adams C, Busby W et al (2006) Comparative in vitro evaluation of microspherical embolisation agents. J Mater Sci Mater Med 17(12):1193-1204
13. Uchida H, Matsuo N, Nishimine K et al (1993) Transcatheter arterial embolization for hepatoma with lipiodol - Hepatic arterial and segmental use. Semin Intervent Radiol 10(1):19-26
14. Choi BI, Kim HC, Han JK et al (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: cT and pathological findings. Radiology 182(3):709-713
15. Tognolini A, Louie JD, Hwang GL et al (2010) Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization. J Vasc Interv Radiol 21(3):339-347
16. Vogl TJ, Trapp M, Schroeder H et al (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success - Results from a liver transplantation center. Radiology 214(2):349-357
17. Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176(3):681-688
18. Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52-60
19. Berber E, Foroutani A, Garland AM et al (2000) Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc 14(9):799-804
20. Herber S, Biesterfeld S, Franz U et al (2008) Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Intervent Radiol 31(4):768-777
21. Fujita T, Ito K, Tanabe M et al (2008) Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography. J Vasc Interv Radiol 19(3):333-341
22. Kloeckner R, Otto G, Biesterfeld S et al (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(3):532-540
23. Moschouris H, Malagari K, Papadaki MG et al (2010) Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis. Cardiovasc Intervent Radiol 33(5):1022-1027
24. Sze DY, Razavi MK, So SK et al (2001) Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AJR Am J Roentgenol 177(6):1339-1345
25. Iwazawa J, Ohue S, Mitani T et al (2009) Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography. AJR Am J Roentgenol 192(4):1057-1063